|
Disease Type
|
Phase / Type
|
Title
|
Physician
|
Contact / Phone
|
Protocol Number
|
 Acute Lymphoblastic Leukemia (ALL)
|
|
Acute Myelogenous Leukemia (AML)
|
 Acute Myelogenous Leukemia (AML) / Myelodysplastic Syndrome (MDS)
|
|
|
II
|
Thiotepa-Clofarabine-Busulfan with Allogeneic and Haploidentical Stem Cell Transplant for High Risk Malignancies
|
Worth, Laura L., M.D., Ph.D.
|
Woodworth, Glenda G., R.N.
(713) 795-2058
|
2008-0363
|
|
|
II
|
Busulfan-Fludarabine-Clofarabine with allogeneic stem cell transplantation for advanced refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome and advanced, Gleevec refractory Chronic Myeloid Leukemia. A Randomized Phase II Study
|
Champlin, Richard E., M.D.
|
Main Switchboard
(713) 792-6161
|
2006-0200
|
|
|
I/II
|
Cord Blood Expansion on Mesenchymal Stem Cells
|
Shpall, Elizabeth, M.D.
|
Main Switchboard
(713) 792-6161
|
2005-0781
|
|
|
I/II
|
Alloreactive NK Cells with Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplantation for AML and MDS
|
Champlin, Richard E., M.D.
|
Main Switchboard
(713) 792-6161
|
2005-0508
|
|
|
I
|
Delayed Infusion of Ex Vivo Anergized Peripheral Blood Mononuclear Cells Following CD34 Selected Peripheral Blood Stem Cell Transplant From A Haploidentical Donor For Patients With Acute Leukemia and Myelodysplasia
|
de Lima, Marcos, M.D.
|
Main Switchboard
(713) 792-6161
|
2005-0695
|
|
Aplastic Anemia
|
|
Brainstem Glioma/ Pontine Glioma
|
|
Central Nervous System (CNS)
|
|
Central Nervous System/Brain Tumors
|
|
Chronic Lymphocytic Leukemia
|
|
Chronic Myeloid Leukemia (CML)
|
|
Ependymoma
|
|
Hodgkin's Disease
|
|
Laboratory
|
|
Medulloblastoma/Primitive Neuroectodermal Tumors (PNET)/Embryonal Tumors
|
|
Non-Hodgkin's Lymphoma
|
|
Other
|
|
Other, Blood/BM Collection
|
|
Pediatric Tumors/Conditions
|
